STOCK TITAN

[SCHEDULE 13G/A] CryoPort, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Brown Capital Management, LLC filed an amended Schedule 13G reporting beneficial ownership of 3,798,962 shares of CryoPort Inc. common stock, representing 7.58% of the class. The filing states Brown Capital has sole voting power over 1,529,549 shares and sole dispositive power over all 3,798,962 shares. The shares are held by various investment advisory clients of Brown Capital, which the firm says gives it beneficial ownership under Rule 13d-3 because of its discretionary authority to direct investment and voting decisions. The filing includes a certification that the holdings are held in the ordinary course of business and are not intended to influence control of the issuer.

Brown Capital Management, LLC ha depositato un emendamento al Schedule 13G riportando la titolarità beneficiaria di 3,798,962 azioni ordinarie di CryoPort Inc., pari al 7.58% della classe. L'atto indica che Brown Capital detiene il potere di voto esclusivo su 1,529,549 azioni e il potere dispositvo esclusivo su tutte le 3,798,962 azioni. Le azioni sono detenute per conto di vari clienti di consulenza per gli investimenti di Brown Capital, e la società afferma che ciò le conferisce la titolarità beneficiaria ai sensi della Rule 13d-3 in virtù della sua autorità discrezionale di indirizzare le decisioni di investimento e di voto. L'emendamento include una certificazione che le partecipazioni sono detenute nell'ordinaria gestione aziendale e non hanno lo scopo di influenzare il controllo dell'emittente.

Brown Capital Management, LLC presentó una enmienda al Schedule 13G notificando la titularidad beneficiaria de 3,798,962 acciones ordinarias de CryoPort Inc., que representan el 7.58% de la clase. En la presentación se indica que Brown Capital tiene el poder de voto exclusivo sobre 1,529,549 acciones y el poder dispositvo exclusivo sobre la totalidad de las 3,798,962 acciones. Las acciones están en manos de varios clientes asesorados por Brown Capital, y la firma afirma que ello le confiere la titularidad beneficiaria conforme a la Rule 13d-3 debido a su autoridad discrecional para dirigir las decisiones de inversión y de voto. La presentación incluye una certificación de que las participaciones se mantienen en el curso ordinario del negocio y no tienen la intención de influir en el control del emisor.

Brown Capital Management, LLC는 수정된 Schedule 13G를 제출하여 CryoPort Inc. 보통주 3,798,962주(해당 등급의 7.58%)에 대한 실질적 소유를 보고했습니다. 제출서에는 Brown Capital이 1,529,549주에 대해 단독 의결권을 보유하고 있으며, 전체 3,798,962주에 대해 단독 처분권을 가지고 있다고 명시되어 있습니다. 해당 주식들은 Brown Capital의 여러 투자자문 고객 명의로 보유되어 있으며, 회사는 투자 및 의결 결정을 지시할 수 있는 재량권 때문에 Rule 13d-3에 따라 실질적 소유를 갖는다고 밝히고 있습니다. 제출서에는 보유가 영업상 통상적인 범위 내에서 이루어졌으며 발행사의 지배권에 영향을 미칠 의도가 없음을 인증하는 내용도 포함되어 있습니다.

Brown Capital Management, LLC a déposé un Schedule 13G modifié déclarant la propriété bénéficiaire de 3,798,962 actions ordinaires de CryoPort Inc., soit 7.58% de la catégorie. Le dépôt précise que Brown Capital détient le pouvoir de vote exclusif sur 1,529,549 actions et le pouvoir de disposition exclusif sur l'ensemble des 3,798,962 actions. Les actions sont détenues pour le compte de divers clients conseillés par Brown Capital, ce qui, selon la société, lui confère la propriété bénéficiaire au titre de la Rule 13d-3 en raison de son pouvoir discrétionnaire de diriger les décisions d'investissement et de vote. Le dépôt inclut une attestation selon laquelle les positions sont détenues dans le cours normal des affaires et n'ont pas pour but d'influencer le contrôle de l'émetteur.

Brown Capital Management, LLC hat eine geänderte Schedule 13G eingereicht, in der sie das wirtschaftliche Eigentum an 3,798,962 Stammaktien von CryoPort Inc. meldet, was 7.58% der Klasse entspricht. In der Einreichung heißt es, dass Brown Capital das alleinige Stimmrecht an 1,529,549 Aktien und die alleinige Verfügungsgewalt über alle 3,798,962 Aktien besitzt. Die Aktien werden für verschiedene Anlageberatungs‑kunden von Brown Capital gehalten, und die Gesellschaft erklärt, dass ihr dadurch nach Rule 13d-3 wirtschaftliches Eigentum zukommt, da sie über die diskretionäre Befugnis verfügt, Anlage- und Stimmrechtsentscheidungen zu steuern. Die Einreichung enthält eine Bestätigung, dass die Positionen im normalen Geschäftsverlauf gehalten werden und nicht dazu bestimmt sind, die Kontrolle über den Emittenten zu beeinflussen.

Positive
  • Material disclosure: Brown Capital reports beneficial ownership of 3,798,962 shares (7.58%) of CryoPort, a clearly reported, material stake.
  • Transparency about nature of ownership: Filing states shares are held for advisory clients and includes a certification that holdings are in the ordinary course of business and not intended to influence control.
Negative
  • None.

Insights

TL;DR: Brown Capital holds a material 7.58% stake (3.8M shares) in CryoPort, reported on an amended Schedule 13G.

This filing discloses a clearly material passive stake by an established investment adviser. The record shows Brown Capital has sole dispositive authority over 3,798,962 shares and sole voting authority over 1,529,549 shares, and it reports the shares are held for advisory clients. The certification in Item 10 indicates the position is held in the ordinary course of business and not for control purposes. For investors, the key facts are the size of the holding and the split between voting and dispositive power; the filing itself does not assert any activist intent.

TL;DR: The schedule shows Brown Capital as a beneficial owner with discretionary authority, noting a voting versus dispositive power split.

The schedule provides governance-relevant facts: Brown Capital is reported as beneficial owner of 7.58% of CryoPort and states the shares are owned for various advisory clients, creating beneficial ownership via discretionary power. The filing quantifies 1,529,549 shares with sole voting power and 3,798,962 shares with sole dispositive power, which may matter in proxy contexts where vote mobilization or disposition timing is relevant. The Item 10 certification confirms the position is presented as non-control seeking under the rules.

Brown Capital Management, LLC ha depositato un emendamento al Schedule 13G riportando la titolarità beneficiaria di 3,798,962 azioni ordinarie di CryoPort Inc., pari al 7.58% della classe. L'atto indica che Brown Capital detiene il potere di voto esclusivo su 1,529,549 azioni e il potere dispositvo esclusivo su tutte le 3,798,962 azioni. Le azioni sono detenute per conto di vari clienti di consulenza per gli investimenti di Brown Capital, e la società afferma che ciò le conferisce la titolarità beneficiaria ai sensi della Rule 13d-3 in virtù della sua autorità discrezionale di indirizzare le decisioni di investimento e di voto. L'emendamento include una certificazione che le partecipazioni sono detenute nell'ordinaria gestione aziendale e non hanno lo scopo di influenzare il controllo dell'emittente.

Brown Capital Management, LLC presentó una enmienda al Schedule 13G notificando la titularidad beneficiaria de 3,798,962 acciones ordinarias de CryoPort Inc., que representan el 7.58% de la clase. En la presentación se indica que Brown Capital tiene el poder de voto exclusivo sobre 1,529,549 acciones y el poder dispositvo exclusivo sobre la totalidad de las 3,798,962 acciones. Las acciones están en manos de varios clientes asesorados por Brown Capital, y la firma afirma que ello le confiere la titularidad beneficiaria conforme a la Rule 13d-3 debido a su autoridad discrecional para dirigir las decisiones de inversión y de voto. La presentación incluye una certificación de que las participaciones se mantienen en el curso ordinario del negocio y no tienen la intención de influir en el control del emisor.

Brown Capital Management, LLC는 수정된 Schedule 13G를 제출하여 CryoPort Inc. 보통주 3,798,962주(해당 등급의 7.58%)에 대한 실질적 소유를 보고했습니다. 제출서에는 Brown Capital이 1,529,549주에 대해 단독 의결권을 보유하고 있으며, 전체 3,798,962주에 대해 단독 처분권을 가지고 있다고 명시되어 있습니다. 해당 주식들은 Brown Capital의 여러 투자자문 고객 명의로 보유되어 있으며, 회사는 투자 및 의결 결정을 지시할 수 있는 재량권 때문에 Rule 13d-3에 따라 실질적 소유를 갖는다고 밝히고 있습니다. 제출서에는 보유가 영업상 통상적인 범위 내에서 이루어졌으며 발행사의 지배권에 영향을 미칠 의도가 없음을 인증하는 내용도 포함되어 있습니다.

Brown Capital Management, LLC a déposé un Schedule 13G modifié déclarant la propriété bénéficiaire de 3,798,962 actions ordinaires de CryoPort Inc., soit 7.58% de la catégorie. Le dépôt précise que Brown Capital détient le pouvoir de vote exclusif sur 1,529,549 actions et le pouvoir de disposition exclusif sur l'ensemble des 3,798,962 actions. Les actions sont détenues pour le compte de divers clients conseillés par Brown Capital, ce qui, selon la société, lui confère la propriété bénéficiaire au titre de la Rule 13d-3 en raison de son pouvoir discrétionnaire de diriger les décisions d'investissement et de vote. Le dépôt inclut une attestation selon laquelle les positions sont détenues dans le cours normal des affaires et n'ont pas pour but d'influencer le contrôle de l'émetteur.

Brown Capital Management, LLC hat eine geänderte Schedule 13G eingereicht, in der sie das wirtschaftliche Eigentum an 3,798,962 Stammaktien von CryoPort Inc. meldet, was 7.58% der Klasse entspricht. In der Einreichung heißt es, dass Brown Capital das alleinige Stimmrecht an 1,529,549 Aktien und die alleinige Verfügungsgewalt über alle 3,798,962 Aktien besitzt. Die Aktien werden für verschiedene Anlageberatungs‑kunden von Brown Capital gehalten, und die Gesellschaft erklärt, dass ihr dadurch nach Rule 13d-3 wirtschaftliches Eigentum zukommt, da sie über die diskretionäre Befugnis verfügt, Anlage- und Stimmrechtsentscheidungen zu steuern. Die Einreichung enthält eine Bestätigung, dass die Positionen im normalen Geschäftsverlauf gehalten werden und nicht dazu bestimmt sind, die Kontrolle über den Emittenten zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Brown Capital Management, LLC
Signature:/s/ Eddie C. Brown
Name/Title:Eddie C. Brown, CEO
Date:08/13/2025

Comments accompanying signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FAQ

How many CryoPort (CYRX) shares does Brown Capital report owning?

Brown Capital reports beneficial ownership of 3,798,962 shares of CryoPort common stock.

What percentage of CYRX does Brown Capital own according to the filing?

The filing states this represents 7.58% of the outstanding class.

What voting and dispositive powers does Brown Capital report for its CYRX holdings?

The filing reports sole voting power over 1,529,549 shares, shared voting power of 0, sole dispositive power over 3,798,962 shares, and shared dispositive power of 0.

Who filed the Schedule 13G/A for CryoPort (CYRX)?

The filer is Brown Capital Management, LLC, a Maryland investment adviser with principal office at 1201 N. Calvert Street, Baltimore, Maryland 21202.

Does the filing indicate Brown Capital seeks to influence control of CryoPort?

No. Item 10 includes a certification that the securities are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of the issuer.

Is the Schedule 13G/A an amendment or an initial filing?

The document is labeled as an amended Schedule 13G ("Amendment No. 7").
Cryoport Inc

NASDAQ:CYRX

CYRX Rankings

CYRX Latest News

CYRX Latest SEC Filings

CYRX Stock Data

425.66M
47.57M
3.67%
98.79%
5.38%
Integrated Freight & Logistics
Pharmaceutical Preparations
Link
United States
BRENTWOOD